评估obicetrapib作为一种新兴的治疗方法,用于患有脱脂症的患者:一个改变游戏规则?
Stephen J Nicholls1, Sean Tan1, Julie Butters1
1Victorian Heart Institute, Monash University, Melbourne, Australia.
Expert opinion on pharmacotherapy
|September 26, 2024
概括
胆固醇转移蛋白 (CETP) 抑制剂,如obicetrapib,通过降低LDL-C显示有望降低心血管风险. 目前正在进行的试验将确定它们对心血管事件的最终影响.
科学领域:
- 脂质代谢和心血管疾病研究.
背景情况:
- 胆固醇转移蛋白 (CETP) 在脂质代谢中至关重要.
- 早期的CETP抑制剂令人失望,但最近的重点是减少心血管风险.
- 较新的CETP抑制剂旨在降低有机脂质,而不仅仅是HDL-C.
研究的目的:
- 总结一下强大的CETP抑制剂obicetrapib的发展情况.
- 为了突出obicetrapib在预防心血管疾病方面的潜力.
主要方法:
- 对CETP抑制和脂质参数数据的审查.
- 专注于obicetrapib在降低apoB和LDL-C的有效性.
主要成果:
- 奥比塞特拉皮有效降低apoB和LDL-C作为单一疗法.
- 当Obicetrapib被添加到高强度他类药物治疗中时,它显示出有效性.
结论:
- 奥比塞特拉皮布代表了预防心血管疾病的潜在策略.
- 目前正在进行的临床试验正在评估obicetrapib对心血管事件的影响.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
584
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
584
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Drugs for Treatment of Constipation-Predominant IBS
143
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
143
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
496
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
496
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Overview of Lipid Metabolism
1.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.1K


